Greatmark Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.8M | Buy |
71,294
+271
| +0.4% | +$92.8K | 2.85% | 10 |
|
|
2026
Q1 | $25M | Buy |
71,023
+272
| +0.4% | +$97K | 2.93% | 11 |
|
|
2025
Q4 | $23.2M | Sell |
70,751
-1,552
| -2% | -$492K | 2.74% | 11 |
|
|
2025
Q3 | $20.4M | Buy |
72,303
+58
| +0.1% | +$16.8K | 2.45% | 15 |
|
|
2025
Q2 | $20.2M | Buy |
72,245
+1,608
| +2% | +$456K | 2.53% | 14 |
|
|
2025
Q1 | $22M | Buy |
70,637
+1,821
| +3% | +$538K | 3% | 10 |
|
|
2024
Q4 | $17.9M | Buy |
68,816
+3,743
| +6% | +$1.11M | 2.44% | 14 |
|
|
2024
Q3 | $21M | Buy |
65,073
+1
| +0% | +$327 | 2.84% | 11 |
|
|
2024
Q2 | $20.3M | Buy |
65,072
+518
| +0.8% | +$152K | 2.97% | 9 |
|
|
2024
Q1 | $18.4M | Buy |
64,554
+2,045
| +3% | +$598K | 2.61% | 13 |
|
|
2023
Q4 | $18M | Buy |
62,509
+205
| +0.3% | +$55.9K | 2.82% | 10 |
|
|
2023
Q3 | $16.7M | Sell |
62,304
-1,496
| -2% | -$373K | 2.96% | 8 |
|
|
2023
Q2 | $14.2M | Buy |
63,800
+2,957
| +5% | +$686K | 2.38% | 16 |
|
|
2023
Q1 | $14.7M | Sell |
60,843
-1,971
| -3% | -$484K | 2.62% | 13 |
|
|
2022
Q4 | $16.5M | Sell |
62,814
-973
| -2% | -$261K | 3.02% | 10 |
|
|
2022
Q3 | $14.4M | Buy |
63,787
+1,055
| +2% | +$256K | 2.78% | 13 |
|
|
2022
Q2 | $15.3M | Buy |
62,732
+52
| +0.1% | +$12.7K | 2.93% | 12 |
|
|
2022
Q1 | $15.2M | Buy |
62,680
+4,635
| +8% | +$1.06M | 2.49% | 14 |
|
|
2021
Q4 | $13.1M | Buy |
58,045
+13,402
| +30% | +$2.83M | 2.19% | 18 |
|
|
2021
Q3 | $9.49M | Buy |
44,643
+7,216
| +19% | +$1.66M | 1.78% | 21 |
|
|
2021
Q2 | $9.12M | Buy |
37,427
+22,341
| +148% | +$5.5M | 1.65% | 23 |
|
|
2021
Q1 | $3.75M | Buy |
15,086
+1,527
| +11% | +$364K | 0.73% | 32 |
|
|
2020
Q4 | $3.12M | Buy |
13,559
+6,201
| +84% | +$1.43M | 0.67% | 36 |
|
|
2020
Q3 | $1.87M | Buy |
7,358
+140
| +2% | +$34.7K | 0.47% | 43 |
|
|
2020
Q2 | $1.7M | Buy |
7,218
+155
| +2% | +$35.4K | 0.45% | 45 |
|
|
2020
Q1 | $1.43M | Buy |
7,063
+580
| +9% | +$127K | 0.46% | 45 |
|
|
2019
Q4 | $1.56M | Buy |
6,483
+1,410
| +28% | +$311K | 0.39% | 50 |
|
|
2019
Q3 | $982K | Buy |
5,073
+2,300
| +83% | +$441K | 0.27% | 60 |
|
|
2019
Q2 | $511K | Buy |
2,773
+760
| +38% | +$136K | 0.15% | 72 |
|
|
2019
Q1 | $382K | Hold |
2,013
| – | – | 0.12% | 85 |
|
|
2018
Q4 | $392K | Buy |
2,013
+750
| +59% | +$146K | 0.14% | 79 |
|
|
2018
Q3 | $262K | Hold |
1,263
| – | – | 0.08% | 104 |
|
|
2018
Q2 | $233K | Hold |
1,263
| – | – | 0.08% | 101 |
|
|
2018
Q1 | $215K | Hold |
1,263
| – | – | 0.08% | 105 |
|
|
2017
Q4 | $220K | Sell |
1,263
-57
| -4% | -$10.1K | 0.08% | 102 |
|
|
2017
Q3 | $246K | Hold |
1,320
| – | – | 0.09% | 97 |
|
|
2017
Q2 | $227K | Hold |
1,320
| – | – | 0.09% | 96 |
|
|
2017
Q1 | $217K | Buy |
+1,320
| New | +$219K | 0.09% | 93 |
|
|
2016
Q4 | – | Sell |
-1,320
| Closed | -$220K | – | 99 |
|
|
2016
Q3 | $220K | Hold |
1,320
| – | – | 0.1% | 85 |
|
|
2016
Q2 | $201K | Buy |
+1,320
| New | +$205K | 0.09% | 88 |
|
|
2016
Q1 | – | Sell |
-1,320
| Closed | -$214K | – | 88 |
|
|
2015
Q4 | $214K | Buy |
+1,320
| New | +$207K | 0.09% | 81 |
|
|
2015
Q3 | – | Sell |
-1,320
| Closed | -$203K | – | 85 |
|
|
2015
Q2 | $203K | Hold |
1,320
| – | – | 0.09% | 83 |
|
|
2015
Q1 | $211K | Hold |
1,320
| – | – | 0.09% | 87 |
|
|
2014
Q4 | $210K | Buy |
+1,320
| New | +$206K | 0.09% | 86 |
|
Other funds holding AMGN
FFM
SP
Greatmark Investment Partners's AMGN Position: Q2 2026 in Review
Greatmark Investment Partners increased its Amgen (AMGN) stake by 0.38% in Q2 2026, buying an estimated $92.8K and bringing the position to 71,294 shares worth $25.8M. The position accounts for 2.85% of the portfolio, ranked #10.
Greatmark Investment Partners first reported a position in AMGN in Q4 2014 and has held it in 44 quarters since. 1,224 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Greatmark Investment Partners held 71,294 shares of Amgen worth $25.8M as of Q2 2026.
- Greatmark Investment Partners bought 271 Amgen shares in Q2 2026, an estimated $92.8K.
- Amgen made up 2.85% of Greatmark Investment Partners's portfolio in Q2 2026, its #10 holding.
- Greatmark Investment Partners first reported a position in Amgen in Q4 2014 and has held it in 44 quarters since.
- 1,224 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Greatmark Investment Partners's 13F filing for Q2 2026, filed 24 Jul 2026.